APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine Enteric Coated Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mesalazine Enteric Coated Tablets Market Analysis and Forecast 2026-2032

Report ID 174012310227 December 2025193 pages

Choose your research edition.

Industry ResearchMesalazine Enteric Coated Tablets Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine Enteric Coated Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Mesalazine Enteric Coated Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine Enteric Coated Tablets Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine Enteric Coated Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Mesalazine Enteric Coated Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mesalazine Enteric Coated Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mesalazine Enteric Coated Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mesalazine Enteric Coated Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mesalazine Enteric Coated Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mesalazine Enteric Coated Tablets include CR Sanjiu, Huahai Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Fosun Pharma, DSM Pharmaceuticals, Dr. Falk Pharma GmbH, Astellas Pharma Inc. and AbbVie Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mesalazine Enteric Coated Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mesalazine Enteric Coated Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Mesalazine Enteric Coated Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mesalazine Enteric Coated Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mesalazine Enteric Coated Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mesalazine Enteric Coated Tablets sales, projected growth trends, production technology, application and end-user industry.

Mesalazine Enteric Coated Tablets Segment by Company

CR Sanjiu

Huahai Pharmaceuticals

UCB Pharma

Sun Pharmaceutical Industries Ltd.

Fosun Pharma

DSM Pharmaceuticals

Dr. Falk Pharma GmbH

Astellas Pharma Inc.

AbbVie Inc.

Mesalazine Enteric Coated Tablets Segment by Type

0.25g

0.5g

1g

Mesalazine Enteric Coated Tablets Segment by Application

Hospital

Clinic

Others

Mesalazine Enteric Coated Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine Enteric Coated Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine Enteric Coated Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine Enteric Coated Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mesalazine Enteric Coated Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mesalazine Enteric Coated Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mesalazine Enteric Coated Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mesalazine Enteric Coated Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.25g Major Manufacturers Table 3. 0.5g Major Manufacturers Table 4. 1g Major Manufacturers Table 5. Global Mesalazine Enteric Coated Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Others Major Manufacturers Table 9. Mesalazine Enteric Coated Tablets Industry Trends Table 10. Mesalazine Enteric Coated Tablets Industry Drivers Table 11. Mesalazine Enteric Coated Tablets Industry Opportunities and Challenges Table 12. Mesalazine Enteric Coated Tablets Industry Restraints Table 13. Global Mesalazine Enteric Coated Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Mesalazine Enteric Coated Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Mesalazine Enteric Coated Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Mesalazine Enteric Coated Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Mesalazine Enteric Coated Tablets Sales by Region (2021-2026) & (Tons) Table 20. Global Mesalazine Enteric Coated Tablets Sales by Region (2027-2032) & (Tons) Table 21. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021-2026) Table 22. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2027-2032) Table 23. Global Mesalazine Enteric Coated Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Mesalazine Enteric Coated Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Mesalazine Enteric Coated Tablets Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Mesalazine Enteric Coated Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Mesalazine Enteric Coated Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Mesalazine Enteric Coated Tablets Manufacturers, Product Type & Application Table 31. Global Mesalazine Enteric Coated Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Mesalazine Enteric Coated Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Mesalazine Enteric Coated Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Mesalazine Enteric Coated Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Mesalazine Enteric Coated Tablets Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons) Table 41. Global Mesalazine Enteric Coated Tablets Sales by Type (2027-2032) & (Tons) Table 42. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2026) Table 43. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2027-2032) Table 44. Global Mesalazine Enteric Coated Tablets Price by Type (2021-2026) & (US$/Ton) Table 45. Global Mesalazine Enteric Coated Tablets Price by Type (2027-2032) & (US$/Ton) Table 46. Global Mesalazine Enteric Coated Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Mesalazine Enteric Coated Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Mesalazine Enteric Coated Tablets Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons) Table 53. Global Mesalazine Enteric Coated Tablets Sales by Application (2027-2032) & (Tons) Table 54. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2026) Table 55. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2027-2032) Table 56. Global Mesalazine Enteric Coated Tablets Price by Application (2021-2026) & (US$/Ton) Table 57. Global Mesalazine Enteric Coated Tablets Price by Application (2027-2032) & (US$/Ton) Table 58. CR Sanjiu Company Information Table 59. CR Sanjiu Business Overview Table 60. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio Table 62. CR Sanjiu Recent Development Table 63. Huahai Pharmaceuticals Company Information Table 64. Huahai Pharmaceuticals Business Overview Table 65. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio Table 67. Huahai Pharmaceuticals Recent Development Table 68. UCB Pharma Company Information Table 69. UCB Pharma Business Overview Table 70. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio Table 72. UCB Pharma Recent Development Table 73. Sun Pharmaceutical Industries Ltd. Company Information Table 74. Sun Pharmaceutical Industries Ltd. Business Overview Table 75. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio Table 77. Sun Pharmaceutical Industries Ltd. Recent Development Table 78. Fosun Pharma Company Information Table 79. Fosun Pharma Business Overview Table 80. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio Table 82. Fosun Pharma Recent Development Table 83. DSM Pharmaceuticals Company Information Table 84. DSM Pharmaceuticals Business Overview Table 85. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio Table 87. DSM Pharmaceuticals Recent Development Table 88. Dr. Falk Pharma GmbH Company Information Table 89. Dr. Falk Pharma GmbH Business Overview Table 90. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio Table 92. Dr. Falk Pharma GmbH Recent Development Table 93. Astellas Pharma Inc. Company Information Table 94. Astellas Pharma Inc. Business Overview Table 95. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio Table 97. Astellas Pharma Inc. Recent Development Table 98. AbbVie Inc. Company Information Table 99. AbbVie Inc. Business Overview Table 100. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio Table 102. AbbVie Inc. Recent Development Table 103. North America Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Mesalazine Enteric Coated Tablets Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons) Table 106. North America Mesalazine Enteric Coated Tablets Sales by Type (2027-2032) & (Tons) Table 107. North America Mesalazine Enteric Coated Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 108. North America Mesalazine Enteric Coated Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 109. North America Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Mesalazine Enteric Coated Tablets Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons) Table 112. North America Mesalazine Enteric Coated Tablets Sales by Application (2027-2032) & (Tons) Table 113. North America Mesalazine Enteric Coated Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 114. North America Mesalazine Enteric Coated Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 115. North America Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 119. North America Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons) Table 120. North America Mesalazine Enteric Coated Tablets Sales by Country (2027-2032) & (Tons) Table 121. North America Mesalazine Enteric Coated Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 122. North America Mesalazine Enteric Coated Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 123. United States Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 124. Canada Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 125. Mexico Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 126. Europe Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Mesalazine Enteric Coated Tablets Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons) Table 129. Europe Mesalazine Enteric Coated Tablets Sales by Type (2027-2032) & (Tons) Table 130. Europe Mesalazine Enteric Coated Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 131. Europe Mesalazine Enteric Coated Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 132. Europe Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Mesalazine Enteric Coated Tablets Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons) Table 135. Europe Mesalazine Enteric Coated Tablets Sales by Application (2027-2032) & (Tons) Table 136. Europe Mesalazine Enteric Coated Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 137. Europe Mesalazine Enteric Coated Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 138. Europe Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 142. Europe Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons) Table 143. Europe Mesalazine Enteric Coated Tablets Sales by Country (2027-2032) & (Tons) Table 144. Europe Mesalazine Enteric Coated Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 145. Europe Mesalazine Enteric Coated Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 146. Germany Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 147. France Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 148. U.K. Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 149. Italy Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 150. Russia Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 151. Spain Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 154. Sweden Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 155. Poland Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 156. China Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & (US$ Million) Table 157. China Mesalazine Enteric Coated Tablets Revenue by Type (2027-2032) & (US$ Million) Table 158. China Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons) Table 159. China Mesalazine Enteric Coated Tablets Sales by Type (2027-2032) & (Tons) Table 160. China Mesalazine Enteric Coated Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 161. China Mesalazine Enteric Coated Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 162. China Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & (US$ Million) Table 163. China Mesalazine Enteric Coated Tablets Revenue by Application (2027-2032) & (US$ Million) Table 164. China Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons) Table 165. China Mesalazine Enteric Coated Tablets Sales by Application (2027-2032) & (Tons) Table 166. China Mesalazine Enteric Coated Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 167. China Mesalazine Enteric Coated Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 168. Asia Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Mesalazine Enteric Coated Tablets Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons) Table 171. Asia Mesalazine Enteric Coated Tablets Sales by Type (2027-2032) & (Tons) Table 172. Asia Mesalazine Enteric Coated Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 173. Asia Mesalazine Enteric Coated Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 174. Asia Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Mesalazine Enteric Coated Tablets Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons) Table 177. Asia Mesalazine Enteric Coated Tablets Sales by Application (2027-2032) & (Tons) Table 178. Asia Mesalazine Enteric Coated Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 179. Asia Mesalazine Enteric Coated Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 180. Asia Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 184. Asia Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons) Table 185. Asia Mesalazine Enteric Coated Tablets Sales by Country (2027-2032) & (Tons) Table 186. Asia Mesalazine Enteric Coated Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 187. Asia Mesalazine Enteric Coated Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 188. Japan Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 189. South Korea Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 190. India Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 191. Australia Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Mesalazine Enteric Coated Tablets Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Mesalazine Enteric Coated Tablets Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Mesalazine Enteric Coated Tablets Sales by Type (2021-2026) & (Tons) Table 197. SAMEA Mesalazine Enteric Coated Tablets Sales by Type (2027-2032) & (Tons) Table 198. SAMEA Mesalazine Enteric Coated Tablets Sales Price by Type (2021-2026) & (US$/Ton) Table 199. SAMEA Mesalazine Enteric Coated Tablets Sales Price by Type (2027-2032) & (US$/Ton) Table 200. SAMEA Mesalazine Enteric Coated Tablets Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Mesalazine Enteric Coated Tablets Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Mesalazine Enteric Coated Tablets Sales by Application (2021-2026) & (Tons) Table 203. SAMEA Mesalazine Enteric Coated Tablets Sales by Application (2027-2032) & (Tons) Table 204. SAMEA Mesalazine Enteric Coated Tablets Sales Price by Application (2021-2026) & (US$/Ton) Table 205. SAMEA Mesalazine Enteric Coated Tablets Sales Price by Application (2027-2032) & (US$/Ton) Table 206. SAMEA Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 210. SAMEA Mesalazine Enteric Coated Tablets Sales by Country (2021-2026) & (Tons) Table 211. SAMEA Mesalazine Enteric Coated Tablets Sales by Country (2027-2032) & (Tons) Table 212. SAMEA Mesalazine Enteric Coated Tablets Sales Price by Country (2021-2026) & (US$/Ton) Table 213. SAMEA Mesalazine Enteric Coated Tablets Sales Price by Country (2027-2032) & (US$/Ton) Table 214. Brazil Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 215. Argentina Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 216. Chile Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 217. Colombia Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 218. Peru Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 220. Israel Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 221. UAE Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 222. Turkey Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 223. Iran Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 224. Egypt Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Mesalazine Enteric Coated Tablets Distributors List Table 228. Mesalazine Enteric Coated Tablets Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Mesalazine Enteric Coated Tablets Image Figure 2. Global Mesalazine Enteric Coated Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine Enteric Coated Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.25g Image Figure 5. 0.5g Image Figure 6. 1g Image Figure 7. Global Mesalazine Enteric Coated Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Mesalazine Enteric Coated Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Others Image Figure 12. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Mesalazine Enteric Coated Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Mesalazine Enteric Coated Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Mesalazine Enteric Coated Tablets Sales (2021-2032) & (Tons) Figure 18. Global Mesalazine Enteric Coated Tablets Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Mesalazine Enteric Coated Tablets Sales YoY (2021-2032) & (Tons) Figure 21. Europe Mesalazine Enteric Coated Tablets Sales YoY (2021-2032) & (Tons) Figure 22. China Mesalazine Enteric Coated Tablets Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Mesalazine Enteric Coated Tablets Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Mesalazine Enteric Coated Tablets Sales YoY (2021-2032) & (Tons) Figure 25. Global Mesalazine Enteric Coated Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Mesalazine Enteric Coated Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Mesalazine Enteric Coated Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Mesalazine Enteric Coated Tablets Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Mesalazine Enteric Coated Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Mesalazine Enteric Coated Tablets Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Mesalazine Enteric Coated Tablets Revenue Share by Type (2021-2032) Figure 41. North America Mesalazine Enteric Coated Tablets Sales Share by Type (2021-2032) Figure 42. North America Mesalazine Enteric Coated Tablets Revenue Share by Application (2021-2032) Figure 43. North America Mesalazine Enteric Coated Tablets Sales Share by Application (2021-2032) Figure 44. North America Mesalazine Enteric Coated Tablets Revenue Share by Country (2021-2032) Figure 45. North America Mesalazine Enteric Coated Tablets Sales Share by Country (2021-2032) Figure 46. Europe Mesalazine Enteric Coated Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Mesalazine Enteric Coated Tablets Sales Share by Type (2021-2032) Figure 48. Europe Mesalazine Enteric Coated Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Mesalazine Enteric Coated Tablets Sales Share by Application (2021-2032) Figure 50. Europe Mesalazine Enteric Coated Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Mesalazine Enteric Coated Tablets Sales Share by Country (2021-2032) Figure 52. China Mesalazine Enteric Coated Tablets Revenue Share by Type (2021-2032) Figure 53. China Mesalazine Enteric Coated Tablets Sales Share by Type (2021-2032) Figure 54. China Mesalazine Enteric Coated Tablets Revenue Share by Application (2021-2032) Figure 55. China Mesalazine Enteric Coated Tablets Sales Share by Application (2021-2032) Figure 56. Asia Mesalazine Enteric Coated Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Mesalazine Enteric Coated Tablets Sales Share by Type (2021-2032) Figure 58. Asia Mesalazine Enteric Coated Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Mesalazine Enteric Coated Tablets Sales Share by Application (2021-2032) Figure 60. Asia Mesalazine Enteric Coated Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Mesalazine Enteric Coated Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Mesalazine Enteric Coated Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Mesalazine Enteric Coated Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Mesalazine Enteric Coated Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Mesalazine Enteric Coated Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Mesalazine Enteric Coated Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Mesalazine Enteric Coated Tablets Sales Share by Country (2021-2032) Figure 68. Mesalazine Enteric Coated Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Mesalazine Enteric Coated Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • CR Sanjiu
  • Huahai Pharmaceuticals
  • UCB Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Fosun Pharma
  • DSM Pharmaceuticals
  • Dr. Falk Pharma GmbH
  • Astellas Pharma Inc.
  • AbbVie Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mesalazine Enteric Coated Tablets Market by Type
  3. 1.2.1 Global Mesalazine Enteric Coated Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.25g
  5. 1.2.3 0.5g
  6. 1.2.4 1g
  7. 1.3 Mesalazine Enteric Coated Tablets Market by Application
  8. 1.3.1 Global Mesalazine Enteric Coated Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Mesalazine Enteric Coated Tablets Market Dynamics
  1. 2.1 Mesalazine Enteric Coated Tablets Industry Trends
  2. 2.2 Mesalazine Enteric Coated Tablets Industry Drivers
  3. 2.3 Mesalazine Enteric Coated Tablets Industry Opportunities and Challenges
  4. 2.4 Mesalazine Enteric Coated Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mesalazine Enteric Coated Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mesalazine Enteric Coated Tablets Revenue by Region
  3. 3.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Mesalazine Enteric Coated Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mesalazine Enteric Coated Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mesalazine Enteric Coated Tablets Sales by Region
  9. 3.4.1 Global Mesalazine Enteric Coated Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mesalazine Enteric Coated Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Mesalazine Enteric Coated Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mesalazine Enteric Coated Tablets Revenue by Manufacturers
  2. 4.1.1 Global Mesalazine Enteric Coated Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mesalazine Enteric Coated Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mesalazine Enteric Coated Tablets Sales by Manufacturers
  6. 4.2.1 Global Mesalazine Enteric Coated Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mesalazine Enteric Coated Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mesalazine Enteric Coated Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mesalazine Enteric Coated Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mesalazine Enteric Coated Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mesalazine Enteric Coated Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Mesalazine Enteric Coated Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mesalazine Enteric Coated Tablets Market CR5 and HHI
  16. 4.8.2 2025 Mesalazine Enteric Coated Tablets Tier 1, Tier 2, and Tier 3
5 Mesalazine Enteric Coated Tablets Market by Type
  1. 5.1 Global Mesalazine Enteric Coated Tablets Revenue by Type
  2. 5.1.1 Global Mesalazine Enteric Coated Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mesalazine Enteric Coated Tablets Sales by Type
  6. 5.2.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mesalazine Enteric Coated Tablets Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mesalazine Enteric Coated Tablets Price by Type
6 Mesalazine Enteric Coated Tablets Market by Application
  1. 6.1 Global Mesalazine Enteric Coated Tablets Revenue by Application
  2. 6.1.1 Global Mesalazine Enteric Coated Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mesalazine Enteric Coated Tablets Sales by Application
  6. 6.2.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mesalazine Enteric Coated Tablets Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mesalazine Enteric Coated Tablets Price by Application
7 Company Profiles
  1. 7.1 CR Sanjiu
  2. 7.1.1 CR Sanjiu Company Information
  3. 7.1.2 CR Sanjiu Business Overview
  4. 7.1.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio
  6. 7.1.5 CR Sanjiu Recent Developments
  7. 7.2 Huahai Pharmaceuticals
  8. 7.2.1 Huahai Pharmaceuticals Company Information
  9. 7.2.2 Huahai Pharmaceuticals Business Overview
  10. 7.2.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
  12. 7.2.5 Huahai Pharmaceuticals Recent Developments
  13. 7.3 UCB Pharma
  14. 7.3.1 UCB Pharma Company Information
  15. 7.3.2 UCB Pharma Business Overview
  16. 7.3.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio
  18. 7.3.5 UCB Pharma Recent Developments
  19. 7.4 Sun Pharmaceutical Industries Ltd.
  20. 7.4.1 Sun Pharmaceutical Industries Ltd. Company Information
  21. 7.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
  22. 7.4.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio
  24. 7.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  25. 7.5 Fosun Pharma
  26. 7.5.1 Fosun Pharma Company Information
  27. 7.5.2 Fosun Pharma Business Overview
  28. 7.5.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio
  30. 7.5.5 Fosun Pharma Recent Developments
  31. 7.6 DSM Pharmaceuticals
  32. 7.6.1 DSM Pharmaceuticals Company Information
  33. 7.6.2 DSM Pharmaceuticals Business Overview
  34. 7.6.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
  36. 7.6.5 DSM Pharmaceuticals Recent Developments
  37. 7.7 Dr. Falk Pharma GmbH
  38. 7.7.1 Dr. Falk Pharma GmbH Company Information
  39. 7.7.2 Dr. Falk Pharma GmbH Business Overview
  40. 7.7.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio
  42. 7.7.5 Dr. Falk Pharma GmbH Recent Developments
  43. 7.8 Astellas Pharma Inc.
  44. 7.8.1 Astellas Pharma Inc. Company Information
  45. 7.8.2 Astellas Pharma Inc. Business Overview
  46. 7.8.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio
  48. 7.8.5 Astellas Pharma Inc. Recent Developments
  49. 7.9 AbbVie Inc.
  50. 7.9.1 AbbVie Inc. Company Information
  51. 7.9.2 AbbVie Inc. Business Overview
  52. 7.9.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio
  54. 7.9.5 AbbVie Inc. Recent Developments
8 North America
  1. 8.1 North America Mesalazine Enteric Coated Tablets Market Size by Type
  2. 8.1.1 North America Mesalazine Enteric Coated Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Mesalazine Enteric Coated Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Mesalazine Enteric Coated Tablets Price by Type (2021-2032)
  5. 8.2 North America Mesalazine Enteric Coated Tablets Market Size by Application
  6. 8.2.1 North America Mesalazine Enteric Coated Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Mesalazine Enteric Coated Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Mesalazine Enteric Coated Tablets Price by Application (2021-2032)
  9. 8.3 North America Mesalazine Enteric Coated Tablets Market Size by Country
  10. 8.3.1 North America Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mesalazine Enteric Coated Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mesalazine Enteric Coated Tablets Market Size by Type
  2. 9.1.1 Europe Mesalazine Enteric Coated Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mesalazine Enteric Coated Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Mesalazine Enteric Coated Tablets Price by Type (2021-2032)
  5. 9.2 Europe Mesalazine Enteric Coated Tablets Market Size by Application
  6. 9.2.1 Europe Mesalazine Enteric Coated Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mesalazine Enteric Coated Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Mesalazine Enteric Coated Tablets Price by Application (2021-2032)
  9. 9.3 Europe Mesalazine Enteric Coated Tablets Market Size by Country
  10. 9.3.1 Europe Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mesalazine Enteric Coated Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mesalazine Enteric Coated Tablets Market Size by Type
  2. 10.1.1 China Mesalazine Enteric Coated Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Mesalazine Enteric Coated Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Mesalazine Enteric Coated Tablets Price by Type (2021-2032)
  5. 10.2 China Mesalazine Enteric Coated Tablets Market Size by Application
  6. 10.2.1 China Mesalazine Enteric Coated Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Mesalazine Enteric Coated Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Mesalazine Enteric Coated Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mesalazine Enteric Coated Tablets Market Size by Type
  2. 11.1.1 Asia Mesalazine Enteric Coated Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mesalazine Enteric Coated Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Mesalazine Enteric Coated Tablets Price by Type (2021-2032)
  5. 11.2 Asia Mesalazine Enteric Coated Tablets Market Size by Application
  6. 11.2.1 Asia Mesalazine Enteric Coated Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mesalazine Enteric Coated Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Mesalazine Enteric Coated Tablets Price by Application (2021-2032)
  9. 11.3 Asia Mesalazine Enteric Coated Tablets Market Size by Country
  10. 11.3.1 Asia Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mesalazine Enteric Coated Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mesalazine Enteric Coated Tablets Market Size by Type
  2. 12.1.1 SAMEA Mesalazine Enteric Coated Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mesalazine Enteric Coated Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mesalazine Enteric Coated Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Mesalazine Enteric Coated Tablets Market Size by Application
  6. 12.2.1 SAMEA Mesalazine Enteric Coated Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mesalazine Enteric Coated Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mesalazine Enteric Coated Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Mesalazine Enteric Coated Tablets Market Size by Country
  10. 12.3.1 SAMEA Mesalazine Enteric Coated Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mesalazine Enteric Coated Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mesalazine Enteric Coated Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mesalazine Enteric Coated Tablets Value Chain Analysis
  2. 13.1.1 Mesalazine Enteric Coated Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mesalazine Enteric Coated Tablets Production Mode & Process
  6. 13.2 Mesalazine Enteric Coated Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mesalazine Enteric Coated Tablets Distributors
  9. 13.2.3 Mesalazine Enteric Coated Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst